Medical Device Outsourcing Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Medical Device Outsourcing Market, By Service

7.1. Medical Device Outsourcing Market, by Service Type, 2023-2032
7.1.1. Product Upgrade Services
7.1.1.1. Market Revenue and Forecast (2020-2032)
7.1.2. Regulatory Affairs Services
7.1.2.1. Market Revenue and Forecast (2020-2032)
7.1.3. Quality Assurance
7.1.3.1. Market Revenue and Forecast (2020-2032)
7.1.4. Product Maintenance Services
7.1.4.1. Market Revenue and Forecast (2020-2032)
7.1.5. Product Testing & Sterilization Services
7.1.5.1. Market Revenue and Forecast (2020-2032)
7.1.6. Product Design and Development Services
7.1.6.1. Market Revenue and Forecast (2020-2032)
7.1.7. Product Implementation Services
7.1.7.1. Market Revenue and Forecast (2020-2032)
7.1.8. Contract Manufacturing
7.1.8.1. Market Revenue and Forecast (2020-2032)

Chapter 8. Global Medical Device Outsourcing Market, By Application

8.1. Medical Device Outsourcing Market, by Application, 2023-2032
8.1.1. Drug Delivery
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Dental
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Diabetes care
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Cardiology
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Endoscopy
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. IVD
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Ophthalmic
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Diagnostic imaging
8.1.8.1. Market Revenue and Forecast (2020-2032)
8.1.9. Orthopedic
8.1.9.1. Market Revenue and Forecast (2020-2032)
8.1.10. General and plastic surgery
8.1.10.1. Market Revenue and Forecast (2020-2032)
8.1.11. Others
8.1.11.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Medical Device Outsourcing Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Service (2020-2032)
9.1.2. Market Revenue and Forecast, by Application (2020-2032)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Service (2020-2032)
9.1.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Service (2020-2032)
9.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Service (2020-2032)
9.2.2. Market Revenue and Forecast, by Application (2020-2032)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Service (2020-2032)
9.2.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Service (2020-2032)
9.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Service (2020-2032)
9.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Service (2020-2032)
9.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Service (2020-2032)
9.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Service (2020-2032)
9.3.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Service (2020-2032)
9.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Service (2020-2032)
9.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Service (2020-2032)
9.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Service (2020-2032)
9.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Service (2020-2032)
9.4.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Service (2020-2032)
9.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Service (2020-2032)
9.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Service (2020-2032)
9.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Service (2020-2032)
9.5.2. Market Revenue and Forecast, by Application (2020-2032)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Service (2020-2032)
9.5.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Service (2020-2032)
9.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

Chapter 10. Company Profiles

10.1. Intertek Group PLC
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. TüvSüd AG
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Wuxi Apptec
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. SGS SA
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Toxikon, INC.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Eurofins Scientific
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. American Preclinical Services
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Sterigenics International LLC
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Pace Analytical Services LLC.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. North American Science Associates, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Charles River Laboratories International, Inc.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms